Multiple pathways regulate Cten in colorectal cancer without a Tensin switch.
(2015)
Journal Article
Thorpe, H., Akhlaq, M., Jackson, D., Al Ghamdi, S., Storr, S., Martin, S., & Ilyas, M. (2015). Multiple pathways regulate Cten in colorectal cancer without a Tensin switch. International Journal of Experimental Pathology, 96(6), 362-369. https://doi.org/10.1111/iep.12154
Outputs (4)
Calpain in Breast Cancer: Role in Disease Progression and Treatment Response (2015)
Journal Article
Storr, S. J., Thompson, N., Pu, X., Zhang, Y., & Martin, S. G. (2015). Calpain in Breast Cancer: Role in Disease Progression and Treatment Response. Pathobiology, 82(3-4), 133-141. https://doi.org/10.1159/000430464
Lymphovascular invasion assessment and prognostic impact in melanoma and breast cancer (2015)
Journal Article
Thompson, N., Storr, S., Zhang, S., & Martin, S. (2015). Lymphovascular invasion assessment and prognostic impact in melanoma and breast cancer. Histology and Histopathology, 30(9), 1001-1009. https://doi.org/10.14670/HH-11-615© 2015, Histology and Histopathology. All rights reserved. The presence of lymphovascular invasion is a recognised poor prognostic factor in a wide range of tumour types. Vascular invasion was historically identified through haematoxylin and eosin st... Read More about Lymphovascular invasion assessment and prognostic impact in melanoma and breast cancer.
FKBPL: a marker of good prognosis in breast cancer (2015)
Journal Article
Nelson, L., McKeen, H. D., Ellis, I., Rakha, E., Marshall, A., Mulrane, L., Starczynski, J., Storr, S. J., Lanigan, F., Byrne, C., Arthur, K., Hegarty, S., Abdunnabi Ali, A., Furlong, F., McCarthy, H. O., Ellis, I. O., Green, A. R., Rakha, E., Young, L., Kunkler, I., …Robson, T. (2015). FKBPL: a marker of good prognosis in breast cancer. Oncotarget, 6(14), 12209-12223. https://doi.org/10.18632/oncotarget.3528FK506-binding protein-like (FKBPL) has established roles as an anti-tumor protein, with a therapeutic peptide based on this protein, ALM201, shortly entering phase I/II clinical trials. Here, we evaluated FKBPL’s prognostic ability in primary breast... Read More about FKBPL: a marker of good prognosis in breast cancer.